Lv1
40 积分 2025-10-20 加入
难治性癌痛专家共识(2017年版)
2天前
已完结
难治性癌痛专家共识（CRPC, 2017年版）解读（一）：难治性癌痛的定义
3天前
已完结
Chinese guidelines for cancer pain management in adults (2025 edition)
3天前
已完结
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
6天前
已完结
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity
6天前
已完结
HDM1002 in Chinese Adults With Overweight/Obesity: A Randomized, Placebo‐Controlled, Ascending‐Dose Phase 1b Study
6天前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
6天前
已完结
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
6天前
已完结
国家基层肥胖症综合管理技术指南（2025）
6天前
已完结
基础胰岛素周制剂依柯胰岛素治疗2型糖尿病临床应用专家指导建议（2025版）
15天前
已完结
皖公网安备34019202002308
